Literature DB >> 3565354

Sex hormone levels in serum in relation to the development of breast cancer.

D K Wysowski, G W Comstock, K J Helsing, H L Lau.   

Abstract

In 1974, approximately 13,000 female residents of Washington County, Maryland, donated 15 ml of blood as part of a project to determine if certain serologic factors were related to the development of site-specific cancer. Sera were stored at -73 C. The present study reports the associations of serum levels of estrone, estradiol, estriol, androstenedione, progesterone, and testosterone with breast cancer among 17 premenopausal cases diagnosed 8-132 months after blood was drawn, and 39 postmenopausal cases diagnosed 6-72 months after blood was drawn. Each case was matched to four controls selected from the other serum bank donors. Matching factors were age, race, and time since last menstrual period. Cases and controls who were taking estrogen-containing preparations were excluded from this analysis. Sera were analyzed without knowledge of case-control status. Differences in levels of serum hormones between cases and controls were slight and not statistically significant.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3565354     DOI: 10.1093/oxfordjournals.aje.a114596

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  40 in total

1.  Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women.

Authors:  A Heather Eliassen; Donna Spiegelman; Xia Xu; Larry K Keefer; Timothy D Veenstra; Robert L Barbieri; Walter C Willett; Susan E Hankinson; Regina G Ziegler
Journal:  Cancer Res       Date:  2011-12-05       Impact factor: 12.701

2.  Combined profile of the tandem repeats CAG, TA and CA of the androgen and estrogen receptor genes in breast cancer.

Authors:  Andrei Anghel; Marius Raica; Catalin Marian; Sorin Ursoniu; Oana Mitrasca
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-22       Impact factor: 4.553

3.  Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk.

Authors:  Susan E Hankinson; A Heather Eliassen
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-24       Impact factor: 4.292

Review 4.  Circulating sex steroids and breast cancer risk in premenopausal women.

Authors:  Susan E Hankinson; A Heather Eliassen
Journal:  Horm Cancer       Date:  2010-02-09       Impact factor: 3.869

Review 5.  Estrogen metabolism and breast cancer.

Authors:  Hamed Samavat; Mindy S Kurzer
Journal:  Cancer Lett       Date:  2014-04-28       Impact factor: 8.679

Review 6.  Epidemiology of endocrine-related risk factors for breast cancer.

Authors:  Leslie Bernstein
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

7.  Prolactin/Stat5 and androgen R1881 coactivate carboxypeptidase-D gene in breast cancer cells.

Authors:  Samir Koirala; Lynn N Thomas; Catherine K L Too
Journal:  Mol Endocrinol       Date:  2014-01-16

Review 8.  Nutrition, hormones, and breast cancer: is insulin the missing link?

Authors:  R Kaaks
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

9.  Reproducibility of fifteen urinary estrogens and estrogen metabolites over a 2- to 3-year period in premenopausal women.

Authors:  A Heather Eliassen; Regina G Ziegler; Bernard Rosner; Timothy D Veenstra; John M Roman; Xia Xu; Susan E Hankinson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-20       Impact factor: 4.254

10.  Exposure, susceptibility, and breast cancer risk: a hypothesis regarding exogenous carcinogens, breast tissue development, and social gradients, including black/white differences, in breast cancer incidence.

Authors:  N Krieger
Journal:  Breast Cancer Res Treat       Date:  1989-07       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.